MRNA | Moderna, Inc.

Index	NDX, S&P 500	P/E	11.28	EPS (ttm)	11.57	Insider Own	2.40%	Shs Outstand	386.00M	Perf Week	3.19%
Market Cap	48.99B	Forward P/E	-	EPS next Y	-4.05	Insider Trans	-19.84%	Shs Float	346.94M	Perf Month	0.28%
Income	4.78B	PEG	-	EPS next Q	-4.12	Inst Own	65.90%	Short Float / Ratio	5.25% / 5.36	Perf Quarter	-8.86%
Sales	15.06B	P/S	3.25	EPS this Y	-29.00%	Inst Trans	0.91%	Short Interest	18.22M	Perf Half Y	-25.81%
Book/sh	48.87	P/B	2.67	EPS next Y	-113.20%	ROA	18.70%	Target Price	216.67	Perf Year	-8.99%
Cash/sh	23.77	P/C	5.49	EPS next 5Y	-	ROE	25.90%	52W Range	115.03 - 217.25	Perf YTD	-27.34%
Dividend	-	P/FCF	80.05	EPS past 5Y	92.10%	ROI	40.60%	52W High	-39.93%	Beta	1.70
Dividend %	-	Quick Ratio	3.30	Sales past 5Y	147.90%	Gross Margin	65.50%	52W Low	13.46%	ATR	5.27
Employees	3900	Current Ratio	3.50	Sales Q/Q	-69.30%	Oper. Margin	32.10%	RSI (14)	47.90	Volatility	3.35% 4.11%
Optionable	Yes	Debt/Eq	0.05	EPS Q/Q	-97.70%	Profit Margin	31.80%	Rel Volume	0.69	Prev Close	128.52
Shortable	Yes	LT Debt/Eq	0.04	Earnings	May 04 BMO	Payout	0.00%	Avg Volume	3.40M	Price	130.51
Recom	2.40	SMA20	0.71%	SMA50	-6.46%	SMA200	-15.22%	Volume	2,354,614	Change	1.55%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-26-23	Initiated	Guggenheim	Neutral
Mar-13-23	Upgrade	TD Cowen	Market Perform → Outperform	$150 → $180
Mar-02-23	Initiated	RBC Capital Mkts	Outperform	$200
Feb-24-23	Downgrade	SVB Securities	Market Perform → Underperform	$111 → $93
Dec-19-22	Upgrade	Jefferies	Hold → Buy	$170 → $275
Dec-14-22	Downgrade	Chardan Capital Markets	Buy → Neutral	$186 → $191
Oct-21-22	Upgrade	SVB Leerink	Underperform → Mkt Perform	$174 → $101
Sep-08-22	Upgrade	Deutsche Bank	Hold → Buy	$165
Feb-01-22	Upgrade	Redburn	Sell → Neutral
Jan-26-22	Upgrade	Deutsche Bank	Sell → Hold	$175
Jan-21-22	Upgrade	BofA Securities	Underperform → Neutral	$135 → $180
Jan-21-22	Initiated	UBS	Neutral	$221
Dec-07-21	Initiated	Cowen	Market Perform
Nov-09-21	Initiated	Wolfe Research	Outperform	$304
Oct-22-21	Initiated	Deutsche Bank	Sell	$250
Oct-15-21	Upgrade	Piper Sandler	Neutral → Overweight	$445
Aug-06-21	Downgrade	Piper Sandler	Overweight → Neutral	$246 → $445
Aug-06-21	Downgrade	Oppenheimer	Outperform → Perform
Jul-15-21	Reiterated	Jefferies	Hold	$170 → $250
Feb-01-21	Downgrade	BofA Securities	Neutral → Underperform

Show Previous Ratings

Jun-03-23 10:00AM	Recent uptick might appease Moderna, Inc. (NASDAQ:MRNA) institutional owners after losing 4.8% over the past year (Simply Wall St.)
Jun-02-23 03:55PM	10 Stocks Jim Cramer and Hedge Funds Have In Common (Insider Monkey)
05:30AM	Better Healthcare AI Stock: Moderna vs. Doximity (Motley Fool)
Jun-01-23 04:05PM	Moderna to Present at Upcoming Conferences in June 2023 (ACCESSWIRE)
12:36PM	Is Moderna Stock A Buy After Unexpectedly Turning A First-Quarter Profit? (Investor's Business Daily)
08:00AM	Loading…
08:00AM	COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring? (Motley Fool)
May-31-23 09:00AM	Heard on the Street: Investors Are Too Bearish on Vaccine-Makers (The Wall Street Journal)
08:00AM	Vaccine Fatigue Can Give Your Portfolio a Booster (The Wall Street Journal)
05:30AM	2 Healthcare AI Stocks to Buy on the Dip (Motley Fool)
May-30-23 10:00AM	Moderna, Inc. (NASDAQ:MRNA) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? (Simply Wall St.)
08:00AM	Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting (ACCESSWIRE)
07:00AM	If You Invested $2,500 in Moderna in 2019, This Is How Much You Would Have Today (Motley Fool)
May-26-23 04:55PM	Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines (Reuters)
01:36PM	Next Covid Boosters Will Target New Strain (The Wall Street Journal)
01:36PM	Next Covid Boosters to Target New Strain (The Wall Street Journal)
05:57AM	Loading…
05:57AM	UPDATE 1-Moderna says looking for opportunities in China after registering legal entity (Reuters)
05:44AM	Moderna says looking for opportunities in China after registering legal entity (Reuters)
04:30AM	Biggest gainers, decliners since the pandemic among Mass. public companies (American City Business Journals)
May-25-23 08:00AM	Possible Bearish Signals With Moderna Insiders Disposing Stock \ (Simply Wall St.)
May-24-23 09:26PM	7 Stocks That Even Company Insiders are Selling (InvestorPlace)
02:14PM	Durham firm inks billion-dollar deal with Novo Nordisk to discover new treatments (American City Business Journals)
11:48AM	Moderna Spikes Amid Covid Fears, but Is It Just a False Positive? (TheStreet.com)
10:16AM	Moderna shares react to Covid resurgence news in China (Yahoo Finance Video)
May-23-23 10:00AM	Is Moderna Stock a Buy Now? (Motley Fool) +8.69%
09:00AM	Is Trending Stock Moderna, Inc. (MRNA) a Buy Now? (Zacks)
05:30AM	3 Stocks You'll Be Glad You Bought at These Prices (Motley Fool)
May-22-23 11:48AM	Moderna (MRNA) Posts Upbeat Data on Protein Replacement Therapy (Zacks)
May-19-23 08:00AM	Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023 (Motley Fool)
07:00AM	Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting (ACCESSWIRE)
May-18-23 10:07AM	Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69% (Motley Fool)
05:30AM	Loading…
05:30AM	3 Magnificent Growth Stocks to Buy to Help Build a Millionaire Portfolio (Motley Fool)
05:26AM	Heres Why You Should Hold Moderna (MRNA) (Insider Monkey)
May-17-23 08:00AM	Ready to Buy the Dip? This Biotech Stock Is a Smart Buy (Motley Fool)
May-16-23 02:00PM	Could Latecomer Moderna Match Big Pharma Rivals in RSV? (Motley Fool)
06:00AM	Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry (PR Newswire)
May-15-23 09:00AM	An Intrinsic Calculation For Moderna, Inc. (NASDAQ:MRNA) Suggests It's 46% Undervalued (Simply Wall St.)
09:00AM	Up 40% in 1 Day, Is Novavax Stock a Buy Now? (Motley Fool)
05:30AM	Is It Too Late to Buy Moderna Stock? (Motley Fool)
May-14-23 12:00AM	Cash-strapped Novavax urges governments to honour Covid jab deals (Financial Times)
May-13-23 06:00AM	Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too (Motley Fool)
May-12-23 10:14AM	Q1 2023 Gritstone bio Inc Earnings Call (Thomson Reuters StreetEvents)
May-11-23 02:00PM	3 Healthcare Stocks to Buy and Hold for the Next 10 Years (Motley Fool)
10:23AM	The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer (Motley Fool)
04:22AM	25 Best Hospitals for Cancer Treatment in the World (Insider Monkey)
May-09-23 04:09PM	15 Biggest Immunotherapy Companies in the World (Insider Monkey)
09:16AM	Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market (Motley Fool)
09:00AM	Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-08-23 04:52PM	Goldman Sachs Top 15 Stock Picks for 2023 (Insider Monkey)
May-07-23 03:13PM	Is Moderna a Value Stock to Buy Right Now? (Motley Fool)
May-06-23 10:00AM	Moderna (NASDAQ:MRNA) climbs 3.1% this week, taking three-year gains to 131% (Simply Wall St.)
05:30AM	Is Moderna Building a Respiratory Vaccine Empire? (Motley Fool)
May-05-23 12:28PM	Moderna, Inc. (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-04-23 07:01PM	Analyst Report: Moderna, Inc. (Morningstar Research)
04:05PM	Moderna Jumps On Unexpected First-Quarter Profit Amid Plummeting Covid Sales (Investor's Business Daily)
03:30PM	Moderna (MRNA) Q1 2023 Earnings Call Transcript (Motley Fool)
02:01PM	Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2% (Zacks)
01:01PM	MODERNA AND NOVOCOL PHARMA ANNOUNCE FILL-FINISH AGREEMENT FOR CANADIAN-MADE MRNA VACCINES (CNW Group)
12:06PM	COVID-19 is not leaving the planet, Moderna CEO says (Yahoo Finance Video)
11:16AM	Moderna tops 1Q forecasts; vaccine sales plunge as expected (AP Finance)
10:34AM	Moderna stock rises on Q1 earnings, positive vaccine guidance (Yahoo Finance Video)
09:19AM	Moderna Jumps After Unexpectedly Reporting Profit In The First Quarter (Investor's Business Daily)
09:16AM	Moderna Posts Earnings Beat. Theres Good News on Covid Vaccines Too. (Barrons.com)
08:05AM	Moderna (MRNA) Q1 Earnings and Revenues Beat Estimates (Zacks)
06:43AM	Moderna Stock Jumps After Earnings Beat. Theres Good News on Covid Vaccines Too. (Barrons.com)
06:40AM	UPDATE 4-Moderna reports surprise profit as it books deferred COVID vaccine sales (Reuters)
06:37AM	Moderna reports surprise profit as it books deferred COVID vaccine sales (Reuters)
06:30AM	Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates (ACCESSWIRE)
06:30AM	Moderna beats COVID vaccine sales expectations as deferred revenue rolls in (Reuters)
05:57AM	These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020 (Motley Fool)
04:14AM	PacWest, First Horizon, Paramount fall premarket; Shopify, Moderna rise (Investing.com)
May-03-23 04:05PM	GSK Stock Jumps After Beating Pfizer, Moderna To The RSV Vaccine Finish Line (Investor's Business Daily)
04:05PM	Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting (ACCESSWIRE)
04:00PM	Moderna to Report Earnings. What Comes After Covid Vaccine Will Be the Focus. (Barrons.com)
11:46AM	Drug, Biotech Stocks' Q1 Earnings on May 4: REGN, ZTS & More (Zacks)
08:34AM	Should You Buy Moderna (MRNA) Ahead of Earnings? (Zacks)
May-02-23 05:15PM	Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines (ACCESSWIRE)
11:40AM	Moderna to Report First Quarterly Loss Since Debuting Covid-19 Vaccine (Investopedia)
08:00AM	In the wake of Moderna, Inc.'s (NASDAQ:MRNA) latest US$1.8b market cap drop, institutional owners may be forced to take severe actions (Simply Wall St.)
06:10AM	The Zacks Analyst Blog Highlights Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins (Zacks)
May-01-23 08:20PM	Why the human genome could be healthcares holy grail (Yahoo Finance Video)
05:15PM	Top Stock Reports for AMD, Cigna & Moderna (Zacks)
12:40PM	Will Pfizer (PFE) Beat Expectations This Earnings Season? (Zacks)
07:44AM	Market Digest: NLY, AJG, BXP, CAT, CMCSA, COF, DPZ, FHI, HES, IP, JNPR, SHW, URI, WM, GM, HA, ABBV, SNAP, MRNA (Argus Research)
07:44AM	Analyst Report: Moderna Inc (Argus Research)
12:00AM	Moderna co-founder calls on US politicians and judges to stop questioning science (Financial Times)
Apr-30-23 09:45AM	This Cathie Wood Stock Is Tanking In 2023. Here's Why You Should Be Buying It (Motley Fool)
12:00AM	BioNTech/Pfizers mooted EU deal for 70mn Covid shots threatens rivals (Financial Times)
Apr-28-23 09:00AM	Could The Market Be Wrong About Moderna, Inc. (NASDAQ:MRNA) Given Its Attractive Financial Prospects? (Simply Wall St.)
08:25AM	Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates? (Zacks)
05:30AM	Better Healthcare AI Buy: Moderna vs. Medronic (Motley Fool)
12:00AM	Moderna tries to show its not a one trick pony (Financial Times)
Apr-27-23 05:50PM	Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know (Zacks)
12:17PM	Is Moderna Stock A Buy Or A Sell On The Long Road For Its Cancer Vaccine? (Investor's Business Daily)
10:02AM	Moderna (MRNA) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
09:00AM	Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
05:25AM	3 Stocks That Could Be Worth More Than Berkshire Hathaway by 2030 (Motley Fool)
Apr-26-23 08:18PM	UPDATE 1-Second judge says US not liable in Moderna COVID-19 vaccine patent case (Reuters)
07:00PM	Modernas CEO shares what it was like to leap from pre-revenue startup to household name and Fortune 500 company (Fortune)
06:59PM	Second judge says US not liable in Moderna COVID-19 vaccine patent case (Reuters)
02:00PM	Better Buy: Pfizer vs. Moderna (Motley Fool)

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bancel Stephane	Chief Executive Officer	Jun 01	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 02 04:46 PM
Bancel Stephane	Chief Executive Officer	Jun 01	Sale	127.96	40,000	5,118,473	5,411,946	Jun 02 04:46 PM
Bancel Stephane	Chief Executive Officer	May 31	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 02 04:46 PM
Bancel Stephane	Chief Executive Officer	May 31	Sale	126.91	40,000	5,076,558	5,411,946	Jun 02 04:46 PM
AFEYAN NOUBAR	Director	May 31	Sale	127.35	15,000	1,910,322	2,172,209	Jun 02 07:00 PM
Hoge Stephen	President	May 30	Sale	124.95	1,181	147,569	1,631,961	May 31 04:21 PM
Bancel Stephane	Chief Executive Officer	May 25	Option Exercise	0.99	40,000	39,600	5,451,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 25	Sale	127.36	40,000	5,094,421	5,411,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 24	Option Exercise	0.99	40,000	39,600	5,451,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 24	Sale	131.43	40,000	5,257,212	5,411,946	May 26 04:59 PM
Bancel Stephane	Chief Executive Officer	May 18	Option Exercise	0.99	40,000	39,600	5,451,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 18	Sale	123.77	40,000	4,950,999	5,411,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 17	Option Exercise	0.99	40,000	39,600	5,451,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 17	Sale	125.32	40,000	5,012,648	5,411,946	May 19 04:12 PM
Bancel Stephane	Chief Executive Officer	May 11	Option Exercise	0.99	40,000	39,600	5,451,946	May 12 04:08 PM
Bancel Stephane	Chief Executive Officer	May 11	Sale	127.26	40,000	5,090,486	5,411,946	May 12 04:08 PM
Bancel Stephane	Chief Executive Officer	May 10	Option Exercise	0.99	40,000	39,600	5,451,946	May 12 04:08 PM
Bancel Stephane	Chief Executive Officer	May 10	Sale	131.60	40,000	5,264,032	5,411,946	May 12 04:08 PM
Hoge Stephen	President	May 10	Sale	133.37	250	33,344	1,630,732	May 11 04:09 PM
Bancel Stephane	Chief Executive Officer	May 04	Option Exercise	0.99	40,000	39,600	5,451,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	May 04	Sale	135.70	40,000	5,428,125	5,411,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	May 03	Option Exercise	0.99	40,000	39,600	5,451,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	May 03	Sale	131.29	40,000	5,251,498	5,411,946	May 05 04:08 PM
Bancel Stephane	Chief Executive Officer	Apr 27	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 27	Sale	130.61	40,000	5,224,570	5,411,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 26	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 26	Sale	131.73	40,000	5,269,140	5,411,946	Apr 28 04:51 PM
Bancel Stephane	Chief Executive Officer	Apr 20	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 20	Sale	142.99	40,000	5,719,540	5,411,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 19	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 19	Sale	142.88	40,000	5,715,262	5,411,946	Apr 21 05:05 PM
Bancel Stephane	Chief Executive Officer	Apr 13	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 13	Sale	160.76	40,000	6,430,340	5,411,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 12	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 12	Sale	156.68	40,000	6,267,335	5,411,946	Apr 14 04:02 PM
Bancel Stephane	Chief Executive Officer	Apr 06	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Apr 06	Sale	157.47	40,000	6,298,950	5,411,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Apr 05	Option Exercise	0.99	40,000	39,600	5,451,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Apr 05	Sale	154.64	40,000	6,185,585	5,411,946	Apr 07 05:31 PM
Bancel Stephane	Chief Executive Officer	Mar 30	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 30	Sale	148.63	40,000	5,945,054	5,411,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 29	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 29	Sale	148.35	40,000	5,934,076	5,411,946	Mar 31 04:10 PM
Bancel Stephane	Chief Executive Officer	Mar 23	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 24 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 23	Sale	149.19	40,000	5,967,683	5,411,946	Mar 24 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 22	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 24 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 22	Sale	150.25	40,000	6,009,804	5,411,946	Mar 24 04:11 PM
Bancel Stephane	Chief Executive Officer	Mar 16	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 17 04:07 PM
Bancel Stephane	Chief Executive Officer	Mar 16	Sale	150.87	40,000	6,034,724	5,411,946	Mar 17 04:07 PM
Bancel Stephane	Chief Executive Officer	Mar 15	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 17 04:07 PM
Bancel Stephane	Chief Executive Officer	Mar 15	Sale	148.81	40,000	5,952,499	5,411,946	Mar 17 04:07 PM
Bancel Stephane	Chief Executive Officer	Mar 09	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 10 04:15 PM
Bancel Stephane	Chief Executive Officer	Mar 09	Sale	139.20	40,000	5,567,859	5,411,946	Mar 10 04:15 PM
Bancel Stephane	Chief Executive Officer	Mar 08	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 10 04:15 PM
Bancel Stephane	Chief Executive Officer	Mar 08	Sale	141.38	40,000	5,655,310	5,411,946	Mar 10 04:15 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 08	Sale	141.51	561	79,388	5,820	Mar 09 04:13 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 07	Option Exercise	0.00	1,138	0	6,381	Mar 09 04:13 PM
Bancel Stephane	Chief Executive Officer	Mar 02	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 03 04:14 PM
Bancel Stephane	Chief Executive Officer	Mar 02	Sale	137.50	40,000	5,500,045	5,411,946	Mar 03 04:14 PM
Hoge Stephen	President	Mar 02	Sale	136.43	1,177	160,583	1,630,460	Mar 03 04:27 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02	Sale	136.43	459	62,623	5,243	Mar 03 04:21 PM
Bancel Stephane	Chief Executive Officer	Mar 01	Option Exercise	0.99	40,000	39,600	5,451,946	Mar 03 04:14 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 01	Option Exercise	0.00	930	0	5,702	Mar 03 04:21 PM
Hoge Stephen	President	Mar 01	Option Exercise	0.00	2,606	0	1,631,637	Mar 03 04:27 PM
Bancel Stephane	Chief Executive Officer	Mar 01	Sale	135.18	40,000	5,407,112	5,411,946	Mar 03 04:14 PM
AFEYAN NOUBAR	Director	Mar 01	Sale	139.00	10,000	1,390,000	2,187,209	Mar 03 07:30 PM
Hoge Stephen	President	Mar 01	Sale	138.03	1,072	147,963	1,629,031	Mar 02 05:31 PM
Hoge Stephen	President	Feb 28	Option Exercise	0.00	2,410	0	1,630,103	Mar 02 05:31 PM
Bancel Stephane	Chief Executive Officer	Feb 23	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 24 04:16 PM
Bancel Stephane	Chief Executive Officer	Feb 23	Sale	146.36	40,000	5,854,202	5,411,946	Feb 24 04:16 PM
Bancel Stephane	Chief Executive Officer	Feb 22	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 24 04:16 PM
Bancel Stephane	Chief Executive Officer	Feb 22	Sale	158.61	40,000	6,344,412	5,411,946	Feb 24 04:16 PM
AFEYAN NOUBAR	Director	Feb 22	Sale	160.35	10,000	1,603,500	2,197,209	Feb 24 07:30 PM
Bancel Stephane	Chief Executive Officer	Feb 16	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 17 04:05 PM
Bancel Stephane	Chief Executive Officer	Feb 16	Sale	173.07	40,000	6,922,947	5,411,946	Feb 17 04:05 PM
Bancel Stephane	Chief Executive Officer	Feb 15	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 17 04:05 PM
Bancel Stephane	Chief Executive Officer	Feb 15	Sale	174.96	40,000	6,998,453	5,411,946	Feb 17 04:05 PM
AFEYAN NOUBAR	Director	Feb 15	Sale	173.17	10,000	1,731,700	2,207,209	Feb 17 07:30 PM
Hoge Stephen	President	Feb 10	Sale	163.90	245	40,156	1,627,693	Feb 13 04:14 PM
Bancel Stephane	Chief Executive Officer	Feb 09	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 10 04:04 PM
Hoge Stephen	President	Feb 09	Option Exercise	0.00	522	0	1,627,938	Feb 13 04:14 PM
Bancel Stephane	Chief Executive Officer	Feb 09	Sale	165.57	40,000	6,622,894	5,411,946	Feb 10 04:04 PM
Bancel Stephane	Chief Executive Officer	Feb 08	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 10 04:04 PM
Bancel Stephane	Chief Executive Officer	Feb 08	Sale	166.00	40,000	6,639,983	5,411,946	Feb 10 04:04 PM
AFEYAN NOUBAR	Director	Feb 08	Sale	167.84	20,000	3,356,761	2,217,209	Feb 10 07:30 PM
Bancel Stephane	Chief Executive Officer	Feb 02	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 03 04:38 PM
Bancel Stephane	Chief Executive Officer	Feb 02	Sale	174.13	40,000	6,965,310	5,411,946	Feb 03 04:38 PM
Bancel Stephane	Chief Executive Officer	Feb 01	Option Exercise	0.99	40,000	39,600	5,451,946	Feb 03 04:38 PM
Bancel Stephane	Chief Executive Officer	Feb 01	Sale	170.19	40,000	6,807,630	5,411,946	Feb 03 04:38 PM
Bancel Stephane	Chief Executive Officer	Jan 26	Option Exercise	0.99	40,000	39,600	5,451,946	Jan 27 04:33 PM
Bancel Stephane	Chief Executive Officer	Jan 26	Sale	190.67	40,000	7,626,788	5,411,946	Jan 27 04:33 PM
Bancel Stephane	Chief Executive Officer	Jan 25	Option Exercise	0.99	40,000	39,600	5,451,946	Jan 27 04:33 PM
Bancel Stephane	Chief Executive Officer	Jan 25	Sale	192.10	40,000	7,683,987	5,411,946	Jan 27 04:33 PM
AFEYAN NOUBAR	Director	Jan 25	Sale	194.33	10,000	1,943,300	2,237,209	Jan 27 07:30 PM
Bancel Stephane	Chief Executive Officer	Jan 19	Option Exercise	0.99	40,000	39,600	5,451,946	Jan 20 04:35 PM
Bancel Stephane	Chief Executive Officer	Jan 19	Sale	192.06	40,000	7,682,289	5,411,946	Jan 20 04:35 PM
Bancel Stephane	Chief Executive Officer	Jan 18	Option Exercise	0.99	40,000	39,600	5,451,946	Jan 20 04:35 PM
Bancel Stephane	Chief Executive Officer	Jan 18	Sale	197.96	40,000	7,918,485	5,411,946	Jan 20 04:35 PM
AFEYAN NOUBAR	Director	Jan 18	Sale	200.20	10,000	2,002,000	2,247,209	Jan 20 07:30 PM
Bancel Stephane	Chief Executive Officer	Jan 12	Option Exercise	0.99	40,000	39,600	5,451,946	Jan 13 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA | Moderna, Inc.

Upgrade your FINVIZ experience